<DOC>
	<DOCNO>NCT02470403</DOCNO>
	<brief_summary>A 12-week study ass LIK066 effect body weight diabetic , prediabetics normoglycemic patient elevate body mass index ( BMI )</brief_summary>
	<brief_title>Effect LIK066 Body Weight Patients With Elevated Body Mass Index</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<criteria>Subjects stable health condition determine past medical history , physical examination , electrocardiogram , laboratory test screen . Patients dysglycemia patient : Fasting plasma glucose &gt; 100mg/dL ( 5.6 mmol/L ) , HbA1c &gt; 5.7 % &lt; 10 % screening . Fasting plasma glucose ≤250mg/dL ( 13.9 mmol/L ) screening . If treat antidiabetic medication ( prohibited medication ) , patient must stable dose 12 week prior randomization maintain dose end study . Subjects must body mass index ( BMI ) within range 35 50 kg/m2 screening , stable body weight ( ± 5 kg ) within 3 month prior screen Preexisting , clinically significant gastrointestinal , liver , cardiovascular , renal chronic medical condition consider serious unstable , stable cardiovascular disease , treat hypertension , dyslipidemia stable chronic disorder Clinically significant GI disorder relate malabsorption may affect drug glucose absorption history significant gastrointestinal surgery could affect intestinal glucose absorption Enrollment diet , weight loss exercise program specific intent lose weight , within 3 month prior randomization , clinical diagnosis eat disorder Pregnant nursing ( lactate ) woman , woman childbearing potential Other inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>dysglycemic , normoglycemic , prediabetes , type 2 diabetes mellitus</keyword>
</DOC>